Exane Derivatives Celsius Holdings, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Celsius Holdings, Inc. stock. As of the latest transaction made, Exane Derivatives holds 4 shares of CELH stock, worth $109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 2,820
99.86%
Holding current value
$109
Previous $155,000
100.0%
% of portfolio
0.0%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding CELH
# of Institutions
581Shares Held
141MCall Options Held
16.9MPut Options Held
17.8M-
Black Rock Inc. New York, NY15.5MShares$425 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$423 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY12.8MShares$352 Million0.14% of portfolio
-
Jpmorgan Chase & CO New York, NY11.1MShares$304 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.61MShares$208 Million0.03% of portfolio
About Celsius Holdings, Inc.
- Ticker CELH
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Beverages—Non-Alcoholic
- Shares Outstandng 75,640,896
- Market Cap $2.07B
- Description
- Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, oran...